DVA vs SCL · P/E 14, rev $12.82B vs P/E 22, rev $2.18B
DaVita HealthCare Partners Inc (DVA) versus Stepan Company (SCL) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Stepan Company (SCL) is a specialty chemicals company listed on US.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Latest reported SCL revenue for 2024-12-31 was $2.18B. Net income was $50.4M. Revenue was down 6.3% from 2023-12-31 to 2024-12-31. SCL currently screens at market cap $1.29B and trailing P/E 22.3.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. SCL currently screens at market cap $1.29B and trailing P/E 22.3.
Not investment advice. Open the DVA and SCL stock pages for the full models.
Not investment advice.